Home › Blood Cancers › Illinois › Chicago
Blood Cancers clinical trials in Chicago, IL
15 studies for Blood Cancers are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- The University of Chicago ( Site 0020), Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- and 1 more
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
RecruitingObservational studyHealthy volunteers welcome
- Tempus AI, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
- Northwestern University Feinberg School of Medicine, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- and 2 more
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RecruitingPhase 3
- Northwestern University, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecruitingPhase 1
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Northwestern Memorial Hospital, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Recruiting
- University of Chicago Comprehensive Cancer Center, Chicago
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RecruitingPhase 1
- Northwestern University - Feinberg School of Medicine, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RecruitingObservational study
- MPN Research Foundation, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Philadelphia, PA14 studies
- Atlanta, GA13 studies
- Nashville, TN13 studies
- Edison, NJ13 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.